Get the best peripheral blood mononuclear cells from patients with various autoimmune disorders

 

Autoimmune disorders are a cluster of rare conditions in which the immune system miss-identifies its own healthy tissues and attacks them by a mechanism called autoimmunity. In autoimmune disorders, the body produces autoantibodies against its normal blood proteins to destroy them. There are several genetic and environmental factors responsible for causing autoimmune disorders. However, the exact cause of this abnormal immune response is still a mystery.

 

Commonly seen autoimmune disorders include Type 1 Diabetes mellitus, Hashimoto's thyroiditis, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, psoriasis, Graves' disease, etc. According to the estimates, millions of people are diagnosed with different autoimmune disorders every year, regardless of their age. However, women have a higher risk to develop autoimmune conditions than men. Of course, autoimmune disorders are lifelong disorders with no permanent cure. Therefore, it is crucial to intensify research to understand autoimmune disorders and their pathway more profound. Discovering the specific causes of immune system overactivity helps to uncover possible ways to control the illnesses in the future.

 

 

 

The unclear disease pathway and unknown etiologies are the main roadblocks for researchers for discovering a permanent cure for autoimmune disorders. Nowadays, Peripheral Blood Mononuclear Cells (PBMC) are considered an effective tissue source for leading molecular and immunological studies in medical research. As we know, peripheral blood mononuclear cells play a crucial role in modifying human immunity. It is hypothesised that the systemic nature of autoimmune disorders can bring clinically relevant modifications or alterations to gene expression of the predisposed individuals' peripheral blood mononuclear cells. On top of it, the high sensitivity and specificity of Peripheral Blood Mononuclear Cells towards genetic diversity and chemical exposure helps the researchers to learn more about adaptive immunity and hyperimmune response. In a nutshell, Peripheral Blood Mononuclear Cells studies can guide to new horizons of pharmacogenomic research to treat immunological disorders.

 

 

Are you looking for Peripheral Blood Mononuclear Cells for your next research project?

Then check out the newest inventory of Central BioHub. www.centralbiohub.de continues to lead the online biospecimen revolution by providing ethically sourced, well-annotated human biospecimens from patients and voluntary donors. Central BioHub offers thousands of accurately tested, well preserved Peripheral Blood Mononuclear Cells isolated from peripheral blood of patients diagnosed with various autoimmune disorders to accelerate active research on immunological disorders worldwide. It offers PBMC, human serum and samples from patients with Type 1 Diabetes mellitus, Hashimoto’s thyroiditis, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, psoriasis, Graves' disease, coeliac disease, and more.

 

For details on the samples and ordering process, browse their latest inventory of banked human specimens at https://centralbiohub.de/Biospecimens/Specimen-Matrix/Peripheral-Blood-Mononuclear-Cell and discover the simplicity of biospecimen procurement.